- Home
- AMLX vs HIO Comparison
AMLX vs HIO Comparison
Compare AMLX & HIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- HIO
- Stock Information
- Founded
- AMLX 2014
- HIO 1993
- Country
- AMLX United States
- HIO United States
- Employees
- AMLX N/A
- HIO N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- HIO Finance/Investors Services
- Sector
- AMLX Health Care
- HIO Finance
- Exchange
- AMLX Nasdaq
- HIO Nasdaq
- Market Cap
- AMLX 330.5M
- HIO 371.4M
- IPO Year
- AMLX 2022
- HIO N/A
- Fundamental
- Price
- AMLX $4.92
- HIO $3.75
- Analyst Decision
- AMLX Buy
- HIO
- Analyst Count
- AMLX 4
- HIO 0
- Target Price
- AMLX $8.50
- HIO N/A
- AVG Volume (30 Days)
- AMLX 815.5K
- HIO 305.3K
- Earning Date
- AMLX 05-08-2025
- HIO 01-01-0001
- Dividend Yield
- AMLX N/A
- HIO 10.33%
- EPS Growth
- AMLX N/A
- HIO N/A
- EPS
- AMLX N/A
- HIO N/A
- Revenue
- AMLX $87,371,000.00
- HIO N/A
- Revenue This Year
- AMLX N/A
- HIO N/A
- Revenue Next Year
- AMLX N/A
- HIO N/A
- P/E Ratio
- AMLX N/A
- HIO N/A
- Revenue Growth
- AMLX N/A
- HIO N/A
- 52 Week Low
- AMLX $1.58
- HIO $3.52
- 52 Week High
- AMLX $7.27
- HIO $4.03
- Technical
- Relative Strength Index (RSI)
- AMLX 74.02
- HIO 42.09
- Support Level
- AMLX $3.79
- HIO $3.71
- Resistance Level
- AMLX $4.05
- HIO $3.76
- Average True Range (ATR)
- AMLX 0.36
- HIO 0.11
- MACD
- AMLX 0.12
- HIO 0.00
- Stochastic Oscillator
- AMLX 98.37
- HIO 60.94
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
About HIO Western Asset High Income Opportunity Fund Inc.
Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.